共 7 条
[1]
Poly(buty1-2-cyanoacrvlate)particl es as adjuvants for oral immu-nization. O’Hagan DT,Palin KJ,Davis SS. Vaccine . 1989
[2]
Orallyadministered microencapsulated Bordetella pertusisfimbrae protect mice from B pertusis respiratory in-fection. Jones DH,McBride BW,Thornton C,et al. Infection and Immunity . 1996
[3]
Protective im-munity against Salmonella Typhimurium elicited inmice by oral vaccination with phosphorylcholine en-capsulated in poly(DL-lactide-co-glycolide)micro-spheres. Khadija AA,Pecquet S,Fattal E,et al. Infection and Immunity . 1997
[4]
Activationpatterns of murine B cells after oral administration ofan encapsulated soluble antigen. Jian SL,Barone KS,Hanagan MP,et al. Vaccine . 1996
[5]
Poly(DL-lac-tide-co-glycolide)-encapsulated plasmid DNA elicitssytemetic and mucocal antibody responses to encodedprotein after oral administration. Jones DH,Corris S,Mcdonald S,et al. Vaccine . 1997
[6]
Enteral im-munization and challenge of volunteers given entero-toxigenic E.coli CFA/Ⅱ encapsulated inbiodegradable microsphere. Tachet CO,Reid RH,Boedeker EC,et al. Vaccine . 1994
[7]
Biodegradable microspheres as a vaccine system. Eldridge JH,Staas JK,Meulbroek JA,et al. Molecular Immunology . 1991